$CCM News

Concord Medical Schedules 2025 Annual Meeting of Shareholders

Concord Medical Reports Financial Results for the First Half of 2025

Concord Medical Services H1 EPS $(0.03), Sales $28.005M Down From $30.109M YoY

Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma

Concord Healthcare's Guangzhou Center Delivers China's First Proton Therapy For Eye Cancer, Offering Vision-Preserving Alternative

Concord Medical Services Holdings Limited (CCM)’s Subsidiary Debuts Nation’s First Proton Therapy LLM

Concord Healthcare Announces Official Release of the Proton Therapy Large Model

Concord Medical Services Holdings Full Year 2024 Earnings: CN¥70.56 loss per share (vs CN¥68.14 loss in FY 2023)

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

Concord Medical Announces Result of 2024 Annual General Meeting

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

Concord Medical Schedules 2024 Annual Meeting of Shareholders

Cadoux Limited Advances Critical Mineral Projects

CCM Stock Dips Amid Declining Financial Performance in the Medical Facilities Sector

Cadoux Limited Secures Major R&D Tax Boost

Cadoux Limited Schedules Upcoming AGM

Cadoux Limited Schedules 2024 Annual Meeting

Canagold’s New Polaris Project Moves Forward

Concord Medical Reports Financial Results for the First Half of 2024

Concord Medical reports 1H results